2013 Q3 Form 10-Q Financial Statement

#000114420413050619 Filed on September 13, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2012 Q3
Revenue $11.12K $7.165K
YoY Change 55.16%
Cost Of Revenue $5.460K $3.578K
YoY Change 52.6%
Gross Profit $5.657K $3.587K
YoY Change 57.71%
Gross Profit Margin 50.89% 50.06%
Selling, General & Admin $113.5K $83.53K
YoY Change 35.91%
% of Gross Profit 2006.84% 2328.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit 0.0% 0.0%
Operating Expenses $119.0K $87.11K
YoY Change 36.6%
Operating Profit -$107.9K -$79.94K
YoY Change 34.94%
Interest Expense $26.81K $17.34K
YoY Change 54.62%
% of Operating Profit
Other Income/Expense, Net $163.2K -$17.34K
YoY Change -1040.99%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $55.32K -$97.28K
YoY Change -156.86%
Net Earnings / Revenue 497.58% -1357.75%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 18.98M shares 18.84M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $70.00K $90.00K
YoY Change -22.22% 350.0%
Cash & Equivalents $69.80K $87.91K
Short-Term Investments
Other Short-Term Assets $130.0K $10.00K
YoY Change 1200.0%
Inventory $568.6K $710.0K
Prepaid Expenses
Receivables $6.545K $10.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $777.7K $820.0K
YoY Change -5.16% -2.38%
LONG-TERM ASSETS
Property, Plant & Equipment $19.04K $10.00K
YoY Change 90.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $19.04K $10.00K
YoY Change 90.4%
TOTAL ASSETS
Total Short-Term Assets $777.7K $820.0K
Total Long-Term Assets $19.04K $10.00K
Total Assets $796.7K $830.0K
YoY Change -4.01% -1.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $77.29K $30.00K
YoY Change 157.63% -50.0%
Accrued Expenses $240.0K $130.0K
YoY Change 84.62% 30.0%
Deferred Revenue
YoY Change
Short-Term Debt $360.0K $310.0K
YoY Change 16.13%
Long-Term Debt Due $130.0K $40.00K
YoY Change 225.0% -66.67%
Total Short-Term Liabilities $804.4K $510.0K
YoY Change 57.73% 27.5%
LONG-TERM LIABILITIES
Long-Term Debt $340.0K $350.0K
YoY Change -2.86% -5.41%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $340.0K $350.0K
YoY Change -2.86% -5.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $804.4K $510.0K
Total Long-Term Liabilities $340.0K $350.0K
Total Liabilities $1.142M $860.0K
YoY Change 32.78% 13.16%
SHAREHOLDERS EQUITY
Retained Earnings -$6.061M
YoY Change
Common Stock $5.716M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$345.2K -$20.00K
YoY Change
Total Liabilities & Shareholders Equity $796.7K $830.0K
YoY Change -4.01% -1.19%

Cashflow Statement

Concept 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income $55.32K -$97.28K
YoY Change -156.86%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities -$160.0K -$140.0K
YoY Change 14.29% -6.67%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$10.00K
YoY Change -100.0% -200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 210.0K 180.0K
YoY Change 16.67% 200.0%
NET CHANGE
Cash From Operating Activities -160.0K -140.0K
Cash From Investing Activities 0.000 -10.00K
Cash From Financing Activities 210.0K 180.0K
Net Change In Cash 50.00K 30.00K
YoY Change 66.67% -137.5%
FREE CASH FLOW
Cash From Operating Activities -$160.0K -$140.0K
Capital Expenditures $0.00 -$10.00K
Free Cash Flow -$160.0K -$130.0K
YoY Change 23.08% -13.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2013-07-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Trading Symbol
TradingSymbol
IVDN
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19005743 shares
dei Entity Registrant Name
EntityRegistrantName
INNOVATIVE DESIGNS INC
dei Entity Central Index Key
EntityCentralIndexKey
0001190370
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
58000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
65000 USD
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19005743 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18935743 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19005743 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18935743 shares
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69800 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54995 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6545 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102350 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
568620 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
623722 USD
CY2013Q3 ivdn Deposits On Inventory
DepositsOnInventory
119602 USD
CY2012Q4 ivdn Deposits On Inventory
DepositsOnInventory
44514 USD
CY2013Q3 us-gaap Prepaid Insurance
PrepaidInsurance
13114 USD
CY2012Q4 us-gaap Prepaid Insurance
PrepaidInsurance
4360 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
777681 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
829941 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19040 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20448 USD
CY2013Q3 us-gaap Assets
Assets
796721 USD
CY2012Q4 us-gaap Assets
Assets
850389 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
77288 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
64455 USD
CY2013Q3 us-gaap Notes Payable Current
NotesPayableCurrent
130331 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
163186 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-119700 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
17342 USD
us-gaap Interest Expense
InterestExpense
71080 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
11117 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
113561 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
114230 USD
us-gaap Interest Paid
InterestPaid
44438 USD
us-gaap Interest Paid
InterestPaid
29790 USD
CY2012Q4 us-gaap Notes Payable Current
NotesPayableCurrent
91298 USD
CY2013Q3 us-gaap Interest Payable Current
InterestPayableCurrent
217501 USD
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
190859 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17342 USD
CY2013Q3 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
357500 USD
CY2012Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
266600 USD
CY2013Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2012Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
190000 USD
CY2013Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21814 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
876 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
804434 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
804088 USD
CY2013Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
337465 USD
CY2012Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
347663 USD
CY2013Q3 us-gaap Liabilities
Liabilities
1141899 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1151751 USD
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
1896 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
1903 USD
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5713638 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5688645 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6060719 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5991903 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-301362 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
-345178 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
796721 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
850389 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7165 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
361173 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
604407 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5460 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3578 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
148275 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
230607 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
113527 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
83528 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
400634 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
493500 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
118987 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
87106 USD
us-gaap Operating Expenses
OperatingExpenses
548909 USD
us-gaap Operating Expenses
OperatingExpenses
724107 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-107870 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-79941 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-187736 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
26814 USD
us-gaap Interest Expense
InterestExpense
53493 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
118920 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-53493 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
55316 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-97283 USD
us-gaap Net Income Loss
NetIncomeLoss
-68816 USD
us-gaap Net Income Loss
NetIncomeLoss
-173193 USD
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18980091 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18843352 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18960118 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18800871 shares
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.003
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.005
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.004
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.009
CY2013Q3 ivdn Reversal Of Contingent Liability
ReversalOfContingentLiability
190000 USD
CY2012Q3 ivdn Reversal Of Contingent Liability
ReversalOfContingentLiability
0 USD
ivdn Reversal Of Contingent Liability
ReversalOfContingentLiability
190000 USD
ivdn Reversal Of Contingent Liability
ReversalOfContingentLiability
0 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
112852 USD
CY2012 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
40500 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-454714 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
25000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
35500 USD
us-gaap Depreciation
Depreciation
1408 USD
us-gaap Depreciation
Depreciation
-325 USD
us-gaap Inventory Write Down
InventoryWriteDown
-7000 USD
us-gaap Inventory Write Down
InventoryWriteDown
-51439 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-95805 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-177419 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-62102 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-83586 USD
ivdn Increase Decrease In Deposits On Inventory
IncreaseDecreaseInDepositsOnInventory
75088 USD
ivdn Increase Decrease In Deposits On Inventory
IncreaseDecreaseInDepositsOnInventory
4433 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
8754 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7469 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12833 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-47263 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
20938 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-5027 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
26642 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
23703 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-104930 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31059 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12109 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12109 USD
ivdn Payment Of Shareholders Advances
PaymentOfShareholdersAdvances
144100 USD
ivdn Payment Of Shareholders Advances
PaymentOfShareholdersAdvances
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
235000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
58500 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
142396 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
33477 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
119735 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22253 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14805 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3303 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91209 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87906 USD
CY2013Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
58000 USD
us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
26000 USD
CY2012 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
54000 USD
CY2013Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
30000 shares
CY2013Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9000 USD
CY2013Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
40000 shares
CY2013Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
16000 USD
CY2013Q1 us-gaap Share Price
SharePrice
0.30
CY2013Q2 us-gaap Share Price
SharePrice
0.40
CY2013Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
255000 USD
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="clear:both;MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0in"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 45pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">NOTE 10.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><u> LITIGATION</u></div> </td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 45pt; FONT: 10pt Times New Roman, Times, Serif"> During 2012, the Company filed a civil complaint in which we asserted that the defendants made deceptive claims in the advertising and promotions that were aimed at our Arctic Armor products. The Company was then named as a defendant in a countersuit that asserted libel, slander, and torturous interference. During June, 2013, a settlement was reached regarding the open litigation. The Company dropped the suit in Pennsylvania, and the defendant dropped the suit in Minnesota. The parties have entered a mutual non-disparagement agreement. As a result, the Company has removed the contingent liability of $<font style=" FONT-SIZE: 10pt">190,000</font> associated with the countersuit.</div> </div>

Files In Submission

Name View Source Status
0001144204-13-050619-index-headers.html Edgar Link pending
0001144204-13-050619-index.html Edgar Link pending
0001144204-13-050619.txt Edgar Link pending
0001144204-13-050619-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
ivdn-20130731.xml Edgar Link completed
ivdn-20130731.xsd Edgar Link pending
ivdn-20130731_cal.xml Edgar Link unprocessable
ivdn-20130731_def.xml Edgar Link unprocessable
ivdn-20130731_lab.xml Edgar Link unprocessable
ivdn-20130731_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
v354764_10q.htm Edgar Link pending
v354764_ex10-1.htm Edgar Link pending
v354764_ex10-2.htm Edgar Link pending
v354764_ex10-3.htm Edgar Link pending
v354764_ex10-4.htm Edgar Link pending
v354764_ex10-5.htm Edgar Link pending
v354764_ex31-1.htm Edgar Link pending
v354764_ex32-1.htm Edgar Link pending